...
首页> 外文期刊>Artificial Organs >The efficacy of HBOC‐201 in ex situ gradual rewarming kidney perfusion in a rat model
【24h】

The efficacy of HBOC‐201 in ex situ gradual rewarming kidney perfusion in a rat model

机译:HBOC-201在大鼠模型中原位逐步复活肾灌注的疗效

获取原文
获取原文并翻译 | 示例

摘要

Abstract Gradual rewarming from hypothermic to normothermic is a novel perfusion modality with superior outcome to sudden rewarming to normothermic. However, the identification of an oxygen carrier that could function at a temperature range from 4 to 7°C or whether it is necessary to use oxygen carrier during kidney rewarming, remains unresolved. This study was designed to test the use of a hemoglobin‐based oxygen carrier (HBOC) during gradual kidney rewarming as an alternative to simple dissolved oxygen. In this study, 10 rat kidneys were randomly divided into the control and the HBOC group. In the control group, no oxygen carrier was used during rewarming perfusion and the perfusion solution was oxygenated only by applying diffused carbogen flow. The protocol mimicked a donor after circulatory death (DCD) kidney transplantation, where after 30 minutes warm ischemia and 120 minutes cold storage in University of Wisconsin?solution, the DCD kidneys underwent gradual rewarming from 10 to 37°C during 90 minutes with or without HBOC. This was followed by 30 minutes of warm ischemia in room temperature to mimic the anastomosis time and 120 minutes of reperfusion at 37°C to mimic the early post‐transplant state of the graft. The HBOC group demonstrated superior kidney function which was highlighted by higher ultrafiltrate production, better glomerular filtration rate and improved sodium reabsorption. There was no significant difference between the 2 groups regarding the hemodynamics, tissue injury, and adenosine triphosphate levels. In conclusion, this study suggests better renal function recovery in DCD kidneys after rewarming with HBOC compared to rewarming without an oxygen carrier.
机译:摘要从低温到NORMOTERMIC的逐步复活是一种新的灌注形态,具有突然复制到常温的卓越结果。然而,鉴定可在4至7℃的温度范围内起作用的氧载体或在肾脏复员期间是否有必要使用氧载体,仍未解决。该研究旨在在逐渐肾脏再次化期间测试血红蛋白的氧载体(HBOC)作为简单溶解氧的替代品。在本研究中,将10只大鼠肾脏随机分为对照和HBOC组。在对照组中,在再次灌注过程中不使用氧载体,并且仅通过施加扩散的碳泡流动灌注溶液。该协议在循环死亡(DCD)肾移植后模仿供体,在威斯康星大学温热缺血和120分钟的冷藏中,DCD肾脏在90分钟内接受了10至37°C的逐渐再次复活。 HBOC。接下来是30分钟的室温温度缺血,以模拟吻合时间和120分钟在37℃下再灌注,以模仿移植的早期移植后状态。 HBOC组展示了优异的肾功能,通过更高的超污水生产,更好的肾小球过滤速率和改善的钠重吸收来突出显示。对于血流动力学,组织损伤和三磷酸腺苷水平之间的2组之间没有显着差异。总之,本研究表明,在没有氧载体的情况下,在重新处理后,通过HBOC再次肾脏在DCD肾脏中恢复更好的肾功能恢复。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号